Navigation Links
Clear Guidelines on Oral Chemotherapy Needed

Current practices around the use of oral chemotherapy in US cancer centres need to be improved, say doctors in a study on bmj.com.

Common malignancies can be treated with oral chemotherapy – a treatment// which is increasingly used across the USA and internationally.

Researchers from Boston set out to analyse the guidelines and practices used by comprehensive cancer centres for the provision of oral chemotherapy. Forty-two centres took part in the study. Variations in practice emerged in the prescribing methods, consent requests and the coordination and monitoring of treatment. They found that few of the safeguards which are routinely used for infusion chemotherapy were adopted for oral chemotherapy treatment.

Most of the 42 organisations which took part in the study had no required elements for prescribing oral chemotherapy and few requested patients’ written consent for off protocol prescribing. Only one in three organisations required a clinician to note the body surface area or calculation of dose on the prescription, and only one in four required the patients’ diagnosis or protocol.

Nearly a quarter of the centres had no formal process for monitoring patients’ adherence. In the past year respondents at 10 centres reported at least one serious adverse drug event related to oral chemotherapy and respondents at 13 centres reported a ‘serious near miss’.

The authors conclude that ‘prescribing, monitoring and coordination, pharmacy practices and education of patients for oral chemotherapy vary substantially. Despite clinicians’ concerns about oral chemotherapies, there is no apparent consensus among oncology professionals about safe practices for these drugs. The oncology community must define safe medication practices appropriate for oral chemotherapy, develop practice guidelines and accelerate their adoption.'

Source-NewswiseBR>SRM
'"/>




Page: 1

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. 21 Women With Breast Cancer Given All Clear By Radiologist
3. The Decks Cleared For HRT - Safe for Menopause Symptoms
4. Laser Used To Clear Blocked Arteries Preventing Amputation
5. Drug Addicts To Prove ‘Child-Caring Capabilities’ By Clearing Drug Tess
6. Neck Artery Treatment Apart From Clearing Plaques Boosts Memory
7. Doctor Cleared Of Charges of Killing a baby
8. New Study Confers All Clear Status On Letrozole, Infertility Drug
9. Nurses Are Furious but the Exact Reason Is Not Clear
10. Helium And MRI Scanning Clearly Detects Smoker Lungs – Research Find
11. Baby Acne Clears Up On Its Own
Post Your Comments:
(Date:3/12/2010)... combines a focus on health and wellness and weight management ... , ... (Vocus) March 12, 2010 ... Natural Products Expo West today as part of the brand’s ... extension of the stage-one product portfolio, builds on the already ...
(Date:3/12/2010)... 1, 2010 new Medicare supplement (Medigap) plans M & N will ... never before seen with Medicare supplements. Precision Senior Marketing, a national ... for the new Medicare Supplement Plan N. , ... ... a national Medicare FMO, announced today that it is providing rates ...
(Date:3/12/2010)... ... , , ... ... ... A new grassroots campaign is expected to generate a million emails from constituents to their Congressional members, opposing ObamaCare.  The One Million ...
(Date:3/12/2010)... of engineers from the CEIT-IK4 technological centre and doctors ... new tool for operating on the inner ear with ... auditory function during the surgery. This is the first ... implants, of which about a hundred are carried out ... new tool were four engineers from CEIT and five ...
(Date:3/12/2010)... ways to make your bedroom a place for ,rest and relaxation ... ... need sleep or how much sleep is recommended for optimal results. But ... decreased to the point where our health and well-being has been impaired. ... decreased productivity, drowsy driving and heart conditions. The people at ...
Breaking Medicine News(10 mins):Health News:Metabolife's New Green Tea + Vitamin D3 Helps Promote Bone Health and Supports Weight Management 2Health News:Medicare Supplement Plan N Information and Rates Now Available Through Precision Senior Marketing 2Health News:Think Tank & Radio Network Encourage Massive Resistance to ObamaCare 2Health News:Think Tank & Radio Network Encourage Massive Resistance to ObamaCare 3Health News:Think Tank & Radio Network Encourage Massive Resistance to ObamaCare 4Health News:CEIT-IK4 designs tool for operations on people with severe or profound auditory loss 2Health News:CEIT-IK4 designs tool for operations on people with severe or profound auditory loss 3Health News:Tips to Create a Dreamy Bedroom to Improve Sleep 2Health News:Tips to Create a Dreamy Bedroom to Improve Sleep 3
... Pistorius files appeal challenging International Association of Athletics Federation ... ... LONDON, Feb. 13 Oscar Pistorius -- a double amputee,athlete from ... today initiated an appeal before the Court of Arbitration for Sport,(CAS) ...
... 2008 The Elsevier Foundation has announced today that it ... institutions from around the world in support of initiatives that ... and medicine. The recipient programs were selected from over 150 ... the developing world and the academic workplace. , ...
... with glasses brought them up to snuff with ... News) -- Preschoolers with poor vision significantly improved ... wearing prescription glasses, a new study shows. , ... have early vision problems that are undiagnosed and ...
... a leading,provider of electronic payment solutions to the ... audit as a Payment Card,Industry (PCI) Level 1 ... are critical in an era when the Federal,Reserve ... 2/3rds,of all U.S. non-cash payments. The Payment Card ...
... ... - 85% Gross Profit ... Prior Year, CHICAGO, Feb. 13 The Female Health Company,(Amex: FHC ), which ... first quarter of,FY2008., For the three months ended December 31, 2007, the Company,s net,revenues ...
... for Continued Growth, CAMBRIDGE, Mass., Feb. 13 Genzyme Corporation,(Nasdaq: ... and,fourth quarter of 2007 and provided an outlook for continued strong ... revenue in 2007 increased 20 percent to $3.8 billion from $3.2 ... broadly driven by growth across all segments ...
Other Medicine News:Health News:Oscar Pistorius Aims to Compete on Level Playing Field at 2008 Beijing Olympics 2Health News:Elsevier Foundation announces grants for innovative libraries and new scholars 2Health News:Fixing Poor Vision Boosts Preschoolers' Test Scores 2Health News:Vanco Services Completes Annual Security Assessment 2Health News:The Female Health Company Reports 37% Revenue Growth and Record Profits for First Quarter of FY2008 2Health News:The Female Health Company Reports 37% Revenue Growth and Record Profits for First Quarter of FY2008 3Health News:The Female Health Company Reports 37% Revenue Growth and Record Profits for First Quarter of FY2008 4Health News:The Female Health Company Reports 37% Revenue Growth and Record Profits for First Quarter of FY2008 5Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 2Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 3Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 4Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 5Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 6Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 7Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 8Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 9Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 10Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 11Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 12Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 13Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 14Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 15Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 16Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 17Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 18Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 19Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 20Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 21Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 22Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 23Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 24
(Date:3/11/2010)... -- With obesity in America reaching alarming levels -- across our adult and youth populations ... BodyMedia,s wearable body-monitoring technology either in conjunction with a group weight loss program or as ... more weight than individuals who attempted to battle the bulge solo. ... ... ...
(Date:3/11/2010)... The U.S. Food and Drug Administration ... drug application (sNDA) of a new six-month 45-mg ... Depot (leuprolide acetate for depot suspension) ... prostate cancer.  Palliative treatment helps to relieve symptoms ... by suppressing the production of the hormone testosterone. ...
(Date:3/11/2010)... On March 10-11, 2010 , the Joint Advisory Committees ... and the Drug Safety and Risk Management Advisory Committees -- discussed the design ... SYMBICORT ® (budesonide/formoterol fumarate dihydrate). , ... ... ...
Breaking Medicine Technology:The Results are in: Users of BodyMedia's Wearable Body-Monitoring Technology Lose 3 Times More Weight 2The Results are in: Users of BodyMedia's Wearable Body-Monitoring Technology Lose 3 Times More Weight 3The Results are in: Users of BodyMedia's Wearable Body-Monitoring Technology Lose 3 Times More Weight 4The Results are in: Users of BodyMedia's Wearable Body-Monitoring Technology Lose 3 Times More Weight 5The Results are in: Users of BodyMedia's Wearable Body-Monitoring Technology Lose 3 Times More Weight 6Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 2Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 3Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 4Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 5Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 6Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 7AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 2AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 3AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 4AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 5AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 6AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 7AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 8Unraveling kidney cancer 64184 1Unraveling kidney cancer 64184 2Unraveling kidney cancer 64184 3Canine compulsive disorder gene identified in dogs 11339 1Canine compulsive disorder gene identified in dogs 11339 2Canine compulsive disorder gene identified in dogs 11339 3Team finds link between stomach cancer bug and cancer promoting factor 11334 1Team finds link between stomach cancer bug and cancer promoting factor 11334 2Team finds link between stomach cancer bug and cancer promoting factor 11334 3
... SAN MATEO, Calif., June 10 /PRNewswire-FirstCall/ - NeurogesX, ... on developing and,commercializing novel pain management therapies, announced ... lead product candidate, NGX-4010, in the,journal Neurology. The ... Treatment of Painful HIV,Neuropathy," will appear in the ...
... a 24-week multi-center, randomized, open-label study presented ... ... Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) today announced data showing ... therapy for 24,weeks resulted in more patients achieving diabetes treatment goals ...
Other Medicine Technology:NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 2NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 3Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 2Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 3Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 4Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 5
... (GH) is a monomeric protein produced and ... gland. GH is released from the pituitary ... under the regulatory control of hypothalamic somatostatin ... timing and frequency of GH release appears ...
... Cortisol is the most potent ... cortex. In plasma, most cortisol is ... globulin (CBG), with the remainder loosely ... specific intracellular receptors with effects in ...
... factor I (IGF-I or somatomedin C) is a ... It acts as a potent mitogen of cellular ... cell-surface receptors. In the circulation, IGF-I is bound ... the actions of IGF-I by modulating the interaction ...
... (PSA) derives its name from its first ... The majority of PSA circulates bound ... Serum concentrations of PSA are elevated in ... (BPH) and prostatitis [1-3]. In addition, PSA ...
Medicine Products: